Hyun Cheol Chung

Hyun Cheol Chung

UNVERIFIED PROFILE

Are you Hyun Cheol Chung?   Register this Author

Register author
Hyun Cheol Chung

Hyun Cheol Chung

Publications by authors named "Hyun Cheol Chung"

Are you Hyun Cheol Chung?   Register this Author

100Publications

4226Reads

32Profile Views

Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study.

Support Care Cancer 2020 Mar 22;28(3):1265-1275. Epub 2019 Jun 22.

Department of Food and Nutrition, Brain Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, 03722, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04924-9DOI Listing
March 2020

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial.

J Cachexia Sarcopenia Muscle 2020 Feb 28;11(1):135-144. Epub 2019 Aug 28.

1st Medical Department, University Cancer Center Leipzig (UCCL), University Leipzig Medical Center, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcsm.12484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015239PMC
February 2020

Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.

Oncologist 2019 Nov 23;24(11):e1108-e1114. Epub 2019 Apr 23.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853112PMC
November 2019

Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer.

Gastric Cancer 2019 11 16;22(6):1153-1163. Epub 2019 May 16.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 51 Yonsei-Ro, Seodaemun-gu, Seoul, 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-019-00971-7DOI Listing
November 2019

Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer.

Radiother Oncol 2019 Nov 11;140:143-149. Epub 2019 Jul 11.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea; Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Project for Medical Sciences, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.06.029DOI Listing
November 2019

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma.

Cancer Res Treat 2019 Oct 16;51(4):1578-1588. Epub 2019 Apr 16.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2018.6
Publisher Site
http://dx.doi.org/10.4143/crt.2018.671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790860PMC
October 2019

Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients.

Cancer Res Treat 2019 Jul 7;51(3):851-860. Epub 2019 Jun 7.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2019.137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639220PMC
July 2019

Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer.

Eur J Cancer 2019 May 19;112:20-28. Epub 2019 Mar 19.

Department of Medical Oncology, Yonsei Cancer Center, Yonsei University Health System, South Korea; Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183153
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.11.029DOI Listing
May 2019

Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.

Oncology 2019 18;96(2):59-69. Epub 2018 Oct 18.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000492597DOI Listing
February 2019

Role of probe-based confocal laser endomicroscopy-targeted biopsy in the molecular and histopathological study of gastric cancer.

J Gastroenterol Hepatol 2019 Jan 4;34(1):84-91. Epub 2018 Oct 4.

Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14471DOI Listing
January 2019

Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.

J Cell Mol Med 2018 12 24;22(12):5899-5908. Epub 2018 Sep 24.

Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.13859DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237558PMC
December 2018

Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer.

Anticancer Res 2018 Nov;38(11):6171-6180

Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/lookup/doi/10.21873/anticanres.12
Publisher Site
http://dx.doi.org/10.21873/anticanres.12970DOI Listing
November 2018

Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.

Int J Cancer 2018 07 23;143(1):151-159. Epub 2018 Feb 23.

Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31304DOI Listing
July 2018

Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.

J Glob Oncol 2018 07;4:1-12

Chia-Jui Yen, National Cheng Kung University Hospital, Tainan; Jin-Yuan Shih, National Taiwan University Hospital; Yee Chao, National Yang-Ming University and Taipei Veterans General Hospital; Rebecca Cheng, Eli Lilly and Company, Taipei, Taiwan; Kei Muro, Aichi Cancer Center Hospital, Nagoya; Masatoshi Kudo, Kindai University School of Medicine, Osaka-Sayama City, Osaka; Kentaro Yamazaki, Shizuoka Cancer Center, Shizuoka, Japan; Tae-Won Kim and Sang-We Kim, Asan Medical Center; JooHyuk Sohn and Hyun Cheol Chung, Yonsei University College of Medicine, Seoul; Keun-Wook Lee, Seoul National University College of Medicine, Seongnam, South Korea; Yawei Zhang and Polina Binder, Eli Lilly and Company, Bridgewater, NJ; Gu Mi, Eli Lilly and Company, Indianapolis, IN, USA; and Mauro Orlando, Eli Lilly and Company, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223521PMC
July 2018

Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer.

Asia Pac J Clin Oncol 2018 Jun 10;14(3):204-209. Epub 2018 Jan 10.

Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12829DOI Listing
June 2018

A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy.

AAPS J 2018 05 29;20(4):72. Epub 2018 May 29.

Department of Pharmacology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12248-018-0223-8DOI Listing
May 2018

The prognostic value of volume-based parameters using F-FDG PET/CT in gastric cancer according to HER2 status.

Gastric Cancer 2018 Mar 22;21(2):213-224. Epub 2017 Jun 22.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-017-0739-0DOI Listing
March 2018

Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.

BMC Cancer 2018 02 7;18(1):158. Epub 2018 Feb 7.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchondong, Seodaemun-gu, Seoul, 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4066-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804074PMC
February 2018

Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.

Asia Pac J Clin Oncol 2017 Dec 16;13(6):365-371. Epub 2017 Mar 16.

Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12681DOI Listing
December 2017

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors.

Invest New Drugs 2017 12 28;35(6):773-781. Epub 2017 Mar 28.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-017-0460-1DOI Listing
December 2017

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer.

Oncotarget 2017 Sep 27;8(37):61837-61845. Epub 2017 Jun 27.

Divison of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617468PMC
September 2017

Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines.

Biochem Pharmacol 2017 08 18;138:163-173. Epub 2017 Apr 18.

Song-Dang Institute for Cancer Research, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; Yonsei Cancer Center, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Department of Internal Medicine, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Project for Medical Sciences, Kangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2017.04.015DOI Listing
August 2017

Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer.

Oncol Lett 2017 Aug 21;14(2):2385-2392. Epub 2017 Jun 21.

Cancer Metastasis Research Center, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2017.6438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530180PMC
August 2017

Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.

Breast Cancer Res Treat 2017 Jun 27;163(2):255-262. Epub 2017 Feb 27.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 120-752, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4175-yDOI Listing
June 2017

Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.

Ann Surg 2017 05;265(5):946-953

*Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA Univerisity, Seongnam, Korea †Yonsei Graduate School, Yonsei University College of Medicine, Seoul, Korea ‡Department of Surgery, Yonsei University College of Medicine, Seoul, Korea §Department of Biostatistics, Graduate School of Public Health, Yonsei University, Seoul, Korea ||Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea ¶Department of internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicinem Guri, Korea **Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea ††Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389602PMC
May 2017

Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab.

Oncotarget 2017 May;8(19):31169-31179

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458198PMC
May 2017

Prevalence and prognostic implications of psychological distress in patients with gastric cancer.

BMC Cancer 2017 04 20;17(1):283. Epub 2017 Apr 20.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3260-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399416PMC
April 2017

ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition.

Biochem Pharmacol 2017 Jan 7;123:73-84. Epub 2016 Nov 7.

Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2016.11.005DOI Listing
January 2017

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.

J Clin Oncol 2016 11 30;34(32):3838-3845. Epub 2016 Sep 30.

Laura Q.M. Chow, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Robert Haddad, Dana-Farber Cancer Institute, Boston, MA; Shilpa Gupta and Amit Mahipal, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Ranee Mehra, Fox Chase Cancer Center, Philadelphia, PA; Joseph Paul Eder and Barbara Burtness, Yale University Cancer Center, New Haven, CT; Hyunseok Kang, Johns Hopkins University, Baltimore, MD; Jared Weiss, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, NC; Amy Meister, Marisa Dolled-Filhart, Kumudu Pathiraja, and Jonathan D. Cheng, Merck, Kenilworth, NJ; Tanguy Y. Seiwert, The University of Chicago, Chicago, IL; Makoto Tahara, National Cancer Center Hospital East, Kashiwa; Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Sourasky Medical Center, Tel-Aviv, Israel; Se-Hoon Lee and Bhumsuk Keam, Seoul National University Hospital; Hyun Cheol Chung, Yonsei University College of Medicine, Seoul, Korea; and Chia-Chi Lin, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804896PMC
November 2016

High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.

J Cancer Res Clin Oncol 2016 Sep 22;142(9):2051-9. Epub 2016 Jul 22.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2208-2DOI Listing
September 2016

A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma.

Cold Spring Harb Mol Case Stud 2016 Sep;2(5):a000992

Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a000992DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002927PMC
September 2016

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.

BMC Cancer 2016 07 8;16:434. Epub 2016 Jul 8.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchondong, Seodaemun-gu, Seoul, 03722, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2451-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938996PMC
July 2016

Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.

Ann Nucl Med 2016 May 2;30(4):279-86. Epub 2016 Feb 2.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12149-016-1059-xDOI Listing
May 2016

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.

Cancer Res Treat 2016 Apr 14;48(2):499-507. Epub 2015 Jul 14.

Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2015.089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843716PMC
April 2016

Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.

Exp Mol Pathol 2016 Apr 25;100(2):287-93. Epub 2015 Nov 25.

Guangdong Provincial Hospital of Traditional Chinese Medicine (GPHTCM), Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexmp.2015.11.027DOI Listing
April 2016

Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.

Ann Surg 2016 Jan;263(1):96-102

*Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea †Department of Biostatistics, Yonsei University College of Medicine, Seoul, Republic of Korea ‡Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea §Department of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001086DOI Listing
January 2016

Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.

Gut 2015 Nov 10;64(11):1721-31. Epub 2014 Nov 10.

Department of Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore, Singapore Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore Cellular and Molecular Research, National Cancer Centre, Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2014-308252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680172PMC
November 2015

The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.

Ann Surg Oncol 2015 Nov 24;22(12):3938-45. Epub 2015 Feb 24.

Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4376-8DOI Listing
November 2015

Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?

Medicine (Baltimore) 2015 Aug;94(33):e1259

From the Department of Radiation Oncology (JSC, JL, KHK, KCK, C-OS, YBK); Division of Medical Oncology, Department of Internal Medicine (JHS, HCC); Department of Surgery (SIK, B-WP); and Yonsei Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea (HCC, YBK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000001259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616432PMC
August 2015

PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity.

Int J Cancer 2015 May 30;136(10):2273-83. Epub 2014 Oct 30.

National Biochip Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea; Cancer Metastasis Research Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea; Yonsei Cancer Research Institute, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29273DOI Listing
May 2015

PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.

Oncology 2015 9;88(2):76-85. Epub 2014 Oct 9.

Oral Cancer Research Institute, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000366426DOI Listing
April 2015

Clinicopathological features and prognostic significance of HER2 expression in gastric cancer.

Oncology 2015 13;88(3):147-56. Epub 2014 Nov 13.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000368555DOI Listing
April 2015

Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.

Ann Surg Oncol 2015 Jan 1;22(1):224-31. Epub 2014 Aug 1.

Department of Pharmacology and Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1245/s10434-014-3949
Web Search
http://link.springer.com/10.1245/s10434-014-3949-2
Publisher Site
http://dx.doi.org/10.1245/s10434-014-3949-2DOI Listing
January 2015

Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children.

Cancer Res Treat 2015 Jan 21;47(1):9-17. Epub 2014 Aug 21.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2013.157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296854PMC
January 2015

Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer.

Am J Cancer Res 2015 15;5(1):72-86. Epub 2014 Dec 15.

Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine Seoul, Korea ; Brain Korea 21 Project for Medical Science, Institute for Cancer Research, Yonsei University College of Medicine Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300687PMC
January 2015

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane.

Cancer Chemother Pharmacol 2014 Oct 9;74(4):799-808. Epub 2014 Aug 9.

Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2551-4DOI Listing
October 2014

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

J Clin Oncol 2014 Jul 27;32(19):2039-49. Epub 2014 May 27.

Taroh Satoh, Kinki University School of Medicine, Osaka; Toshihiko Doi and Atsushi Ohtsu, National Cancer Center Hospital East, Chiba; Akihito Tsuji, Kochi Health Sciences Center, Kochi; Yasushi Omuro, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital; Akihira Mukaiyama and Mikiro Kobayashi, GlaxoSmithKline, Tokyo; Hiroto Miwa, Hyogo College of Medicine, Hyogo, Japan; Rui-Hua Xu, Sun Yat-Sen University Cancer Center, Guangzhou; Guo-Ping Sun, First Affiliated Hospital of Anhui Medical University, Hefei; Jian-Ming Xu, 307 Hospital of the People's Liberation Army; Jin-Wan Wang, Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Beijing; Jin Li, Fudan University Cancer Hospital, Shanghai; Shu-Kui Qin, People's Liberation Army 81 Hospital; Ji-Feng Feng, Cancer Hospital of Jiangsu Province, Nanjing, People's Republic of China; Hyun Cheol Chung, Yonsei Cancer Center, Yonsei University College of Medicine; Yung-Jue Bang, Seoul National University College of Medicine, Seoul; Ik-Joo Chung, Chonnam National University Hwasun Hospital, Jeollanamdo, South Korea; and Kun-Huei Yeh, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/05/20/JCO.2013.53
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.53.6136
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.53.6136DOI Listing
July 2014

Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer.

J Psychosom Res 2014 Jul 5;77(1):76-80. Epub 2014 May 5.

Department of Psychiatry, Yonsei University College of Medicine, Seoul, South Korea; The Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychores.2014.04.008DOI Listing
July 2014

Quality of life in the trastuzumab for gastric cancer trial.

Oncologist 2014 Jul 20;19(7):712-9. Epub 2014 Jun 20.

Osaka University Graduate School of Medicine, Osaka, Japan; Seoul National University College of Medicine, Seoul, Republic of Korea; Ivanovo Regional Oncology Dispensary, Ivanovo, Russian Federation; Tochigi Cancer Center, Utsunomiya, Japan; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Institute of Oncology, St. Petersburg, Russian Federation; National Cancer Center Hospital East, Kashiwa, Japan; University Hospital Gasthuisberg, Leuven, Belgium; F. Hoffmann-La Roche Ltd., Basel, Switzerland; Roche Products, Sydney, New South Wales, Australia; Yonsei Cancer Center, Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077451PMC
July 2014

High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients.

World J Surg Oncol 2014 Jul 24;12:232. Epub 2014 Jul 24.

Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7819-12-232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119179PMC
July 2014

Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer.

Pathology 2014 Jun;46(4):316-24

1Department of Pathology, Yanbian University Hospital, Yanji City, Jilin Province, China 2Oral Cancer Research Institute, College of Dentistry, Yonsei University, Seoul, South Korea 3Department of Dermatology, Yanbian University Hospital, Yanji City, Jilin Province, China 4Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul 5Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 6Department of Surgery, Yonsei University College of Medicine, Seoul 7Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000094DOI Listing
June 2014

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.

BMC Cancer 2013 Dec 6;13:583. Epub 2013 Dec 6.

Yonsei Cancer Center, Divison of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029391PMC
December 2013

Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.

J Clin Oncol 2013 Nov 16;31(31):3935-43. Epub 2013 Sep 16.

Atsushi Ohtsu, National Cancer Center Hospital East, Kashiwa; Keisho Chin, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo; Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan; Jaffer A. Ajani, University of Texas MD Anderson Cancer Center, Houston, TX; Tarek Sahmoud, Heind Smith, Syed Rizvi, David Lebwohl, Novartis Pharmaceuticals, Florham Park, NJ; Yu-Xian Bai, Tumor Hospital of Harbin Medical University, Harbin; Hong-Ming Pan, Sir Run Run Shaw Hospital, Zhejiang; Lin Shen, Peking University Cancer Hospital, Beijing, People's Republic of China; Yung-Jue Bang, Seoul National University College of Medicine; Hyun-Cheol Chung, Yonsei Cancer Center, Yonsei University College of Medicine; Yeul Hong Kim, Korea University Anam Hospital, Seoul, South Korea; Kun-Huei Yeh, National Taiwan University Hospital, Taipei, Taiwan, Republic of China; David Ferry, New Cross Hospital, Wolverhampton, United Kingdom; Niall C. Tebbutt, Austin Health, Heidelberg, Australia; Salah-Eddin Al-Batran, Institute for Clinical Oncology Research, Krankenhaus Nordwest, UCT University Cancer Center, Frankfurt, Germany; Chiara Costantini, Novartis Pharma AG, Basel, Switzerland; Eric Van Cutsem, University Hospitals Leuven and KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.3552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950503PMC
November 2013

Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.

J Clin Oncol 2013 Nov 30;31(32):4067-75. Epub 2013 Sep 30.

Ann-Lii Cheng, National Taiwan University Hospital, Taipei; Deng-Yn Lin, Chang Gung Memorial Hospital, Chang Gung University, Guishan Township, Taiwan, Republic of China; Yoon-Koo Kang, Asan Medical Center, University of Ulsan College of Medicine; Hyun-Cheol Chung, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul; Joong-Won Park, National Cancer Center, Goyang, Republic of Korea; Masatoshi Kudo, Kinki University Hospital, Osaka; Masao Omata, Yamanashi Prefecture Central Hospital, Kofu, Yamanashi, Japan; Shukui Qin, Nanjing Bayi Hospital, Nanjing; Xiangqun Song, Tumor Hospital of Guangxi Zhuang Autonomous Region, Nanning; Jianming Xu, Beijing 307 Hospital Cancer Centre, Beijing, People's Republic of China; Guido Poggi, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Maugeri, Pavia; Silvana Lanzalone, Maria Jose Lechuga, Pfizer Italia Srl, Milan, Italy; Susan Pitman Lowenthal, Pfizer Oncology, New York, NY; Liqiang Yang, Pfizer Oncology, La Jolla, CA; Eric Raymond, Service Inter Hospitalier de Cancerologie Bichat-Beaujon, Clichy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.8372DOI Listing
November 2013

Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.

Jpn J Clin Oncol 2013 Oct 20;43(10):996-1003. Epub 2013 Aug 20.

*Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt117DOI Listing
October 2013